Lack of PTEN sequesters CHK1 and initiates genetic instability

Cancer Cell

Volumn 7, Issue 2, 2005, Pages 193-204

  Puc, Janusz ^a,b   Keniry, Megan ^a   Li, Hong Shen ^a   Pandita, Tej K ^c   Choudhury, Atish D ^a   Memeo, Lorenzo ^a   Mansukhani, Mahesh ^a   Murty, Vundavalli V V S ^a   Gaciong, Zbigniew ^b   Meek, Sarah E M ^c   Piwnica Worms, Helen ^c   Hibshoosh, Hanina ^a   Parsons, Ramon ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25A; CHECKPOINT KINASE 1; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SERINE; UBIQUITIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELLULAR DISTRIBUTION; CHEMICAL BINDING; CONTROLLED STUDY; COVALENT BOND; CYTOPLASM; EMBRYO; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION CARCINOGENESIS;

ANIMALIA;

EID: 13844251972     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.01.009     Document Type: Article

References (59)

1. I. Adini, I. Rabinovitz, J.F. Sun, G.C. Prendergast, and L.E. Benjamin RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development Genes Dev. 17 2003 2721 2732
2. S.A. Backman, D. Ghazarian, K. So, O. Sanchez, K.U. Wagner, L. Hennighausen, A. Suzuki, M.S. Tsao, W.B. Chapman, V. Stambolic, and T.W. Mak Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten Proc. Natl. Acad. Sci. USA 101 2004 1725 1730
3. V. Baldin, N. Theis-Febvre, C. Benne, C. Froment, M. Cazales, O. Burlet-Schiltz, and B. Ducommun PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation Biol. Cell. 95 2003 547 554
4. J. Bartek, and J. Lukas Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell 3 2003 421 429
5. D.W. Bell, J.M. Varley, T.E. Szydlo, D.H. Kang, D.C. Wahrer, K.E. Shannon, M. Lubratovich, S.J. Verselis, K.J. Isselbacher, and J.F. Fraumeni Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 1999 2528 2531
6. R. Bernardi, D.A. Liebermann, and B. Hoffman Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation Oncogene 19 2000 2447 2454
7. A. Blasina, I.V. de Weyer, M.C. Laus, W.H. Luyten, A.E. Parker, and C.H. McGowan A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase Curr. Biol. 9 1999 1 10
8. I. Blomberg, and I. Hoffmann Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases Mol. Cell. Biol. 19 1999 6183 6194
9. S. Bose, A. Crane, H. Hibshoosh, M. Mansukhani, L. Sandweis, and R. Parsons Reduced expression of PTEN correlates with breast cancer progression Hum. Pathol. 33 2002 405 409
10. M.G. Cangi, B. Cukor, P. Soung, S. Signoretti, G. Moreira Jr., M. Ranashinge, B. Cady, M. Pagano, and M. Loda Role of the Cdc25A phosphatase in human breast cancer J. Clin. Invest. 106 2000 753 761
11. C.E. Canman, D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 Science 281 1998 1677 1679
12. L.C. Cantley, and B.G. Neel New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc. Natl. Acad. Sci. USA 96 1999 4240 4245
13. M.S. Chen, C.E. Ryan, and H. Piwnica-Worms Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding Mol. Cell. Biol. 23 2003 7488 7497
14. A.D. Choudhury, H. Xu, and R. Baer Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression J. Biol. Chem. 279 2004 33909 33918
15. D. Cortez, Y. Wang, J. Qin, and S.J. Elledge Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks Science 286 1999 1162 1166
16. S.J. Elledge Cell cycle checkpoints: Preventing an identity crisis Science 274 1996 1664 1672
17. N. Fujita, S. Sato, K. Katayama, and T. Tsuruo Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization J. Biol. Chem. 277 2002 28706 28713
18. K. Galaktionov, A.K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach CDC25 phosphatases as potential human oncogenes Science 269 1995 1575 1577
19. Z. Guo, A. Kumagai, S.X. Wang, and W.G. Dunphy Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts Genes Dev. 14 2000 2745 2756
20. A. Hirao, Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, and T.W. Mak DNA damage-induced activation of p53 by the checkpoint kinase Chk2 Science 287 2000 1824 1827
21. K. Jiang, E. Pereira, M. Maxfield, B. Russell, D.M. Goudelock, and Y. Sanchez Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345 J. Biol. Chem. 278 2003 25207 25217
22. E.S. Kandel, J. Skeen, N. Majewski, A. Di Cristofano, P.P. Pandolfi, C.S. Feliciano, A. Gartel, and N. Hay Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage Mol. Cell. Biol. 22 2002 7831 7841
23. Y.S. Kaneko, N. Watanabe, H. Morisaki, H. Akita, A. Fujimoto, K. Tominaga, M. Terasawa, A. Tachibana, K. Ikeda, M. Nakanishi, and Y. Kaneko Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase Oncogene 18 1999 3673 3681
24. M.B. Kastan, Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia Cell 71 1992 587 597
25. T. Kimura, A. Suzuki, Y. Fujita, K. Yomogida, H. Lomeli, N. Asada, M. Ikeuchi, A. Nagy, T.W. Mak, and T. Nakano Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production Development 130 2003 1691 1700
26. F.W. King, J. Skeen, N. Hay, and E. Shtivelman Inhibition of Chk1 by Activated PKB/Akt Cell Cycle 3 2004 634 637
27. H. Kishimoto, K. Hamada, M. Saunders, S. Backman, T. Sasaki, T. Nakano, T.W. Mak, and A. Suzuki Physiological functions of pten in mouse tissues Cell Struct. Funct. 28 2003 11 21
28. M.H. Lam, Q. Liu, S.J. Elledge, and J.M. Rosen Chk1 is haploinsufficient for multiple functions critical to tumor suppression Cancer Cell 6 2004 45 59
29. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, and R. McCombie PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
30. J. Liang, J. Zubovitz, T. Petrocelli, R. Kotchetkov, M.K. Connor, K. Han, J.H. Lee, S. Ciarallo, C. Catzavelos, and R. Beniston PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat. Med. 8 2002 1153 1160
31. Q. Liu, S. Guntuku, X.S. Cui, S. Matsuoka, D. Cortez, K. Tamai, G. Luo, S. Carattini-Rivera, F. DeMayo, and A. Bradley Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint Genes Dev. 14 2000 1448 1459
32. Y. Lu, Y.Z. Lin, R. LaPushin, B. Cuevas, X. Fang, S.X. Yu, M.A. Davies, H. Khan, T. Furui, and M. Mao The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells Oncogene 18 1999 7034 7045
33. T. Maehama, and J.E. Dixon The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J. Biol. Chem. 273 1998 13375 13378
34. N. Mailand, J. Falck, C. Lukas, R.G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas Rapid destruction of human Cdc25A in response to DNA damage Science 288 2000 1425 1429
35. D. Malkin, F.P. Li, L.C. Strong, J.F. Fraumeni Jr., C.E. Nelson, D.H. Kim, J. Kassel, M.A. Gryka, F.Z. Bischoff, and M.A. Tainsky Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
36. L.D. Mayo, and D.B. Donner A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus Proc. Natl. Acad. Sci. USA 98 2001 11598 11603
37. L.D. Mayo, J.E. Dixon, D.L. Durden, N.K. Tonks, and D.B. Donner PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy J. Biol. Chem. 277 2001 5484 5489
38. K. Podsypanina, L.H. Ellenson, A. Nemes, J. Gu, M. Tamura, K.M. Yamada, C. Cordon-Cardo, G. Catoretti, P.E. Fisher, and R. Parsons Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proc. Natl. Acad. Sci. USA 96 1999 1563 1568
39. L. Rossig, A.S. Jadidi, C. Urbich, C. Badorff, A.M. Zeiher, and S. Dimmeler Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells Mol. Cell. Biol. 21 2001 5644 5657
40. Y. Saito, X. Swanson, A.M. Mhashilkar, Y. Oida, R. Schrock, C.D. Branch, S. Chada, L. Zumstein, and R. Ramesh Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo Gene Ther. 10 2003 1961 1969
41. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, and S. Sfez A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
42. I. Shin, F.M. Yakes, F. Rojo, N.Y. Shin, A.V. Bakin, J. Baselga, and C.L. Arteaga PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization Nat. Med. 8 2002 1145 1152
43. E. Shtivelman, J. Sussman, and D. Stokoe A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle Curr. Biol. 12 2002 919 924
44. J.D. Siliciano, C.E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M.B. Kastan DNA damage induces phosphorylation of the amino terminus of p53 Genes Dev. 11 1997 3471 3481
45. C.S. Sorensen, R.G. Syljuasen, J. Falck, T. Schroeder, L. Ronnstrand, K.K. Khanna, B.B. Zhou, J. Bartek, and J. Lukas Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A Cancer Cell 3 2003 247 258
46. C.H. Spruck, K.A. Won, and S.I. Reed Deregulated cyclin E induces chromosome instability Nature 401 1999 297 300
47. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39
48. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, A.H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, and T. Davis Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat. Genet. 15 1997 356 362
49. M.L. Sulis, and R. Parsons PTEN: From pathology to biology Trends Cell Biol. 13 2003 478 483
50. A. Suzuki, M.T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, and M. Fukumoto T cell-specific loss of Pten leads to defects in central and peripheral tolerance Immunity 14 2001 523 534
51. H. Takai, K. Tominaga, N. Motoyama, Y.A. Minamishima, H. Nagahama, T. Tsukiyama, K. Ikeda, K. Nakayama, M. Nakanishi, and K. Nakayama Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice Genes Dev. 14 2000 1439 1447
52. R.S. Tibbetts, D. Cortez, K.M. Brumbaugh, R. Scully, D. Livingston, S.J. Elledge, and R.T. Abraham Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress Genes Dev. 14 2000 2989 3002
53. L.C. Trotman, M. Niki, Z.A. Dotan, J.A. Koutcher, A.D. Cristofano, A. Xiao, A.S. Khoo, P. Roy-Burman, N.M. Greenberg, and T.V. Dyke Pten dose dictates cancer progression in the prostate PLoS Biol. 1 2003 e59 10.1371/journal.pbio. 0000059
54. S. Wang, J. Gao, Q. Lei, N. Rozengurt, C. Pritchard, J. Jiao, G.V. Thomas, G. Li, P. Roy-Burman, and P.S. Nelson Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Cancer Cell 4 2003 209 221
55. M.J. Wishart, and J.E. Dixon PTEN and myotubularin phosphatases: From 3-phosphoinositide dephosphorylation to disease. Phosphatase and tensin homolog deleted on chromosome ten Trends Cell Biol. 12 2002 579 585
56. J.A. Wright, K.S. Keegan, D.R. Herendeen, N.J. Bentley, A.M. Carr, M.F. Hoekstra, and P. Concannon Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control Proc. Natl. Acad. Sci. USA 95 1998 7445 7450
57. H. Zhao, and H. Piwnica-Worms ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1 Mol. Cell. Biol. 21 2001 4129 4139
58. H. Zhao, J.L. Watkins, and H. Piwnica-Worms Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints Proc. Natl. Acad. Sci. USA 99 2002 14795 14800
59. B.P. Zhou, Y. Liao, W. Xia, Y. Zou, B. Spohn, and M.C. Hung HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nat. Cell Biol. 3 2001 973 982